INTRODUCTION: Eosinophil-derived neurotoxin (EDN) is a biomarker for eosinophilic activation. Urinary (u) EDN may allow non-invasive monitoring of asthma, but clinical recommendations are lacking. We assessed the potential of uEDN as a marker of disease activity in pediatric asthma. METHODS: We assessed urine samples of 371 children from the German ALLIANCE study cohort, from which we had: 169 preschool wheezers (<6 years), 80 asthmatics (
- Omony, J.
- Thölken, C.
- Salimi, A.
- Laubhahn, K.
- Illi, S.
- Weckmann, M.
- Grychtol, R.
- Rabe, K. F.
- Thiele, D.
- Foth, S.
- Weber, S.
- Brinkmann, F.
- Kopp, M. V.
- Hansen, G.
- Renz, H.
- von Mutius, E.
- Schaub, B.
- Skevaki, C.
Keywords
- Humans
- *Asthma/urine/diagnosis/physiopathology
- *Eosinophil-Derived Neurotoxin/urine
- Male
- Female
- Child
- Child, Preschool
- *Biomarkers/urine
- Eosinophils/immunology
- Immunoglobulin E/blood
- Lung/physiopathology
- Respiratory Function Tests/methods
- Adolescent
- T2‐high phenotype
- atopy
- biomarker
- children
- eosinophil‐derived neurotoxin
- preschool wheeze